Compare DRTS & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | CDRE |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | Israel | United States |
| Employees | 121 | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | N/A | 2021 |
| Metric | DRTS | CDRE |
|---|---|---|
| Price | $13.15 | $33.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.67 | ★ $39.67 |
| AVG Volume (30 Days) | ★ 553.0K | 377.6K |
| Earning Date | 05-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.46% |
| EPS Growth | N/A | ★ 13.33 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $610,308,000.00 |
| Revenue This Year | N/A | $23.72 |
| Revenue Next Year | $699.98 | $6.89 |
| P/E Ratio | ★ N/A | $112.97 |
| Revenue Growth | N/A | ★ 7.53 |
| 52 Week Low | $3.01 | $25.73 |
| 52 Week High | $14.11 | $48.76 |
| Indicator | DRTS | CDRE |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 70.02 |
| Support Level | $11.24 | $27.76 |
| Resistance Level | $14.00 | $44.70 |
| Average True Range (ATR) | 0.80 | 1.66 |
| MACD | -0.02 | 0.28 |
| Stochastic Oscillator | 69.05 | 74.37 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments - the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products.